Format

Send to

Choose Destination
Kidney Int. 2018 Feb;93(2):292-295. doi: 10.1016/j.kint.2017.12.002.

REPRISE: tolvaptan in advanced polycystic kidney disease.

Author information

1
Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: Christina.wyatt@mssm.edu.
2
Department of Nephrology, University Hospital La Cavale Blanche, Université de Bretagne Occidentale, Brest, France.

KEYWORDS:

ADPKD; chronic kidney disease; vasopressin

PMID:
29389391
DOI:
10.1016/j.kint.2017.12.002
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center